National Cannabis Review
Industry Links
Medical Links
  Home   
Recreational

Greetings,
The National Cannabis Review offers daily marijuana news and is one of the most comprehensive directories of medical dispensaries, retail pot stores and the cannabis industry in the nation. We support legalization by communicating well written news and up to date information about respected businesses.

Please help us provide more accurate information by sending a submission, correction or review. If a listed business is closed or unsatisfactory, please let us know.

Thanks for your support, we can make the difference by working together.
Mark

Upcomming Events

Add an event








Legalized In Navada!
Yes — 54 percent





Legalized In Oregon!
Yes - 55 percent
No - 45 percent





Legalized In Alaska!
Yes — 52 percent
No — 48 percent





Legalized In DC!
Yes - 69 percent
No — 31 percent





Legalize It World Wide!


National Cannabis Industry News    Search Industry News: 
The Washington Post | August 15
 Corona brewer boosts stake in marijuana producer for $4B
In this May 31, 2018, file photo the logo for Canadas Canopy Growth Corp. appears on a screen above a trading post on the floor of the New York Stock Exchange. The parent company of Corona beer and other alcoholic drinks is expanding its partnership with a Canadian pot producer, betting on the continued growth in the medical and recreational cannabis markets. Constellation Brands Inc. said Wednesday, Aug. 15, that its buying 104.5 million shares worth $4 billion in Canopy Growth Corp.
In this May 31, 2018, file photo the logo for Canadas Canopy Growth Corp. appears on a screen above a trading post on the floor of the New York Stock Exchange. The parent company of Corona beer and other alcoholic drinks is expanding its partnership with a Canadian pot producer, betting on the continued growth in the medical and recreational cannabis markets. Constellation Brands Inc. said Wednesday, Aug. 15, that its buying 104.5 million shares worth $4 billion in Canopy Growth Corp.
(image:Richard Drew, File/Associated Press)
Associated Press
The parent company of Corona beer and other alcoholic drinks is expanding its partnership with a Canadian pot producer, betting on the continued growth in the medical and recreational cannabis markets. Constellation Brands Inc. said Wednesday its buying 104.5 million shares worth $4 billion in Canopy Growth Corp., boosting its stake in the company to 38 percent after its existing warrants are exercised. The companies said the investment is the largest one to date in the cannabis sector. Constellation originally invested in Canopy last October. Constellation will also get....
View more in new window
| August 14th, 2018
 California Bureau of Cannabis Control accepting public comments on proposed rules


Kate Zawidzki
Members of the public are invited to provide comments on Californias proposed rules for cannabis businesses. The Bureau of Cannabis Control and other agencies seek public comments as they consider a permanent set of rules replacing those temporarily in place. For background, including the text of the proposed rules, summaries, and the agencies reasoning for seeking changes, visit the states website. Comments must be received by 5:00 p.m. on Monday, August 27. For the most part, permanent rules would mirror those currently in place but there are some key differences. A b....
View more in new window
Marijuana Business Daily | August 13, 2018
 Ontario scraps government monopoly, adopts private retail plan for adult-use cannabis market


Matt Lamers
Ontarios new retail framework for recreational cannabis will start with online-only sales when legalization takes effect Oct. 17, with a network of privately owned stores expected to be in place by April 1. The new retail plan, first reported by Marijuana Business Daily, is a complete overhaul of the previous governments commitment to opening only a small number of publicly owned stores. The change was unveiled at a Monday afternoon news conference by Attorney General Caroline Mulroney and Finance Minister Vic Fedeli. Some key details include: Privately owned retai....
View more in new window
The Weed Blog | 8/16/2018
 Last Ditch Lawsuit Claims Utahs MMJ Ballot Violates Mormons Religious Beliefs


A second lawsuit has been filed to block legalization by members of the Church or Jesus Christ of Latter-day Saints.
Members of the Church of Jesus Christ of Latter-day Saints, now filing their second lawsuit to block voters from legalizing medical cannabis, are attempting to prove that the ballot initiative, Proposition 2, violates their religious beliefs. Proponents of the measure have called the lawsuit a wacky attempt to stop Utahns from voting on it this coming November. The group leading the lawsuit say the MMJ legalization measure would violate the religious beliefs of one Walter J. Plumb, an attorney and active member of Mormon Church who also happens to be the primary financier....
View more in new window
NORML | August 9, 2018
 NORML PAC Endorses Senator Bernie Sanders for Reelection


The National Organization for the Reform of Marijuana Laws Political Action Committee NORML PAC has endorsed Senator Bernie Sanders in his campaign for reelection in Vermont. Bernie has become one of the most outspoken and visible advocates for ending marijuana prohibition, stated NORML PAC Executive Director Erik Altieri, He has called for sensible drug policy throughout his career, made descheduling marijuana a key component of his platform when running for the Democratic nomination for President in 2016, and has co-sponsored key pieces of federal legislation such as the....
View more in new window
The Joint Blog | August 13, 2018
 Study: Cannabis Terpenes have Anti-Inflammatory, Antioxidant, Analgesic, Anticonvulsive, Antidepressant, Anxiolytic, Anticancer, Antitumor, Neuroprotective, Anti-Mutagenic, Anti-Allergic, Antibiotic and Anti-Diabetic Attributes


Anthony Martinelli

A new study has found that cannabis terpenes have attributes that are anti-inflammatory, antioxidant, analgesic, anticonvulsive, antidepressant, anxiolytic, anticancer, antitumor, neuroprotective, anti-mutagenic, anti-allergic, antibiotic and anti-diabetic.
The study was published by the European Journal of Medicinal Chemistry. Its abstract starts by stating that Cannabaceae plants Cannabis sativa L. and Humulus lupulus L. are rich in terpenes both are typically comprised of terpenes as up to 3-5 percent of the dry-mass of the female inflorescence. Some terpenes are relatively well known for their potential in biomedicine and have been used in traditional medicine for centuries, while others are yet to be studied in detail. With that in mind, The current, comprehensive review presents terpenes found in cannabis and hops. The....
View more in new window
The Weed Blog | 8/13/18
 Its Official: North Dakota Legalization Activists Gather Enough Signatures


Travis Maurer
LegalizeND has submitted enough signatures to qualify a marijuana legalization initiative for this Novembers ballot. Make that more than enough. On Monday Aug 13, North Dakota Secretary of State Al Jaeger confirmed that LegalizeND has submitted more than enough signatures to qualify a marijuana legalization initiative for this Novembers ballot. Activists submitted more than 18,000 signatures to qualify the full legalization measure. After random sampling, officials determined that 15,039 were valid, exceeding the number needed to qualify for the ballot, which is 13,452. ....
View more in new window
The Weed Blog | 8/13/18
 Hawaii Update: Big Island Still Waiting to Open Dispensaries


Travis Maurer
Six out of eight dispensaries that sell MMJ in Hawaii have opened on all the major islands except Hawaii Island. Although it has been a year since Hawaii legalized recreational cannabis and nearly a decade since it approved medical, there are still no retail dispensaries selling cannabis on the Big Island. Six out of eight dispensaries that sell MMJ in Hawaii have opened on all the major islands except Hawaii Island, which has by far the most medical patients, according to the Honolulu Star Advertiser. A Big Island dispensary was expected to open as early in December 201....
View more in new window
The Weed Blog | 8/13/18
 Hawaii Update: Big Island Still Waiting to Open Dispensaries
Travis Maurer
Six out of eight dispensaries that sell MMJ in Hawaii have opened on all the major islands except Hawaii Island. Although it has been a year since Hawaii legalized recreational cannabis and nearly a decade since it approved medical, there are still no retail dispensaries selling cannabis on the Big Island. Six out of eight dispensaries that sell MMJ in Hawaii have opened on all the major islands except Hawaii Island, which has by far the most medical patients, according to the Honolulu Star Advertiser. A Big Island dispensary was expected to open as early in December 201....
View more in new window
NORML | August 8, 2018
 New Federal Employment Protections Bill Introduced For Marijuana Consumers
Today, Congressman Charlie Crist held a press conference to announce the introduction of the Fairness in Federal Drug Testing Under State Laws Act, HR 6589. The bipartisan bill would explicitly bar federal agencies from discriminating against workers solely because of their status as a cannabis consumer, or due to testing positive for marijuana use on a workplace drug test. Send a message to your Representative in support of this bill now Medical marijuana is an issue of compassion, and in the veterans community, access is even more important as more and more veterans ar....
View more in new window
Marijuana Business Daily | August 8, 2018
 Too much of a good thing in Oregon as cannabis businesses adapt to flooded market


Bart Schaneman
Theres one major pain point for Oregon marijuana business owners that eclipses all others: a supply glut caused by too much cannabis and insufficient demand. The surplus of wholesale cannabis has shifted the dynamics of the states MJ industry. It has forced growers to cut costs and eliminate staff. And it has created a buyers market for retailers stocking up on low-priced product. It used to be a growers market, said Shane McKee, chief cultivator of vertically integrated company Shango, based in the Portland area. But with todays supply glut, the leverage has shifted in f....
View more in new window
The Joint Blog | August 9, 2018
 Recently the United States Food and Drug Administration FDA, for the first time ever, gave approval to a marijuana-based medicine. The company behind the medicine now says he expects the government to reschedule cannabis within 90 days.


Anthony Martinelli
We expect to make Epidiolex available to U.S. patients this fall, following rescheduling which is expected to occur within 90 days of FDA approval, said GW Pharmarceuticals CEO Justin Grover in a recent earnings call. We have been building commercial inventory in recent months and are in a position to ship product into the U.S. supply chain, once rescheduling is complete. In June, Epidiolex became the first marijuana-derived medicine to ever be approved by the FDA. According to Grover, roughly 1,200 people in other countries are currently receiving Epidiolex, mostly for Le....
View more in new window
The Joint Blog | August 10, 2018
 Study: Legalizing Medical Marijuana Associated with a 33.7 Reduction in Workplace Fatalities Among Those Aged 25 to 44


Anthony Martinelli

According to a new study published by the International Journal of Drug Policy, the legalization of medical marijuana is associated with a large decrease in workplace fatalities .
According to its abstract, the aim of the study was to determine the association between legalizing medical marijuana and workplace fatalities. Using data from all 50 states and the District of Columbia between 1992 and 2015 obtained from the Bureau of Labor Statistics, regression models were adjusted for state demographics, the unemployment rate, state fixed effects, and year fixed effects. Legalizing medical marijuana was associated with a 19.5 percent reduction in the expected number of workplace fatalities among workers aged 2544, states the study. This associated grew....
View more in new window
The Joint Blog | August 10, 2018 Facebook Twitter Reddit Google Pinterest
 Study: Legalizing Medical Marijuana Associated with a 33.7 Reduction in Workplace Fatalities Among Those Aged 25 to 44
Anthony Martinelli

According to a new study published by the International Journal of Drug Policy, the legalization of medical marijuana is associated with a large decrease in workplace fatalities .
According to its abstract, the aim of the study was to determine the association between legalizing medical marijuana and workplace fatalities. Using data from all 50 states and the District of Columbia between 1992 and 2015 obtained from the Bureau of Labor Statistics, regression models were adjusted for state demographics, the unemployment rate, state fixed effects, and year fixed effects. Legalizing medical marijuana was associated with a 19.5 percent reduction in the expected number of workplace fatalities among workers aged 2544, states the study. This associated grew....
View more in new window
Older cannabis industry news.

You Can Help Leaglize It.
Take Action Now!



Its Time Michigan
Michigan





New Approach
South Dakota





Regulating Marijuana Like Alcohol
Vermont





Decriminalization Bill 868
Virginia

Home
Mission Statement
Privacy Statement
Rating System
Submit
Link Back
Contact Mark
© Copyright 2017
We make every effort to provide timely and accurate information, however we cannot guaranty the accuracy of these listings.
To correct a listing, please use the corrections link or contact the web master, Mark.
This web site contains no advertising. Listings in this directory are licensed business.
Reviews and editorials are the opinion of the author only, not those of the National Cannabis Review.
No Sign In -- Minimum Digital Footprint
Reduce violence on the border, support local growers, keep your cash in your community, and get consistent quality Legalize It World Wide!.